Trending News Today: Kentucky Launches Investigation Into PBM Practices

Kentucky Attorney General Andy Beshear announced an investigation into allegations that pharmacy benefit managers (PBMs) overcharged state health insurance programs for drugs and discriminated against independent pharmacies, Reuters reported. According to the article, a recently-released report indicated that 2 PBMs took in $123.5 million last year from Kentucky’s Medicaid program by paying pharmacies a lower rate to fill prescriptions and charged the state more. Beshear said in a statement that he was seeking details on how PBMs determined, billed, and paid drug reimbursement rates over the past 5 years, the article reported.
 
New poll data indicate that Americans increasingly want greater government spending on health care, The Associated Press reported. According to the article, an analysis of data from the General Social Survey showed that 7 in 10 consider the government’s spending on improving national health to be too low, up from 62% in 2016. The poll found 80% of Democrats indicated there is too little spending and 59% of Republicans said the same, both up from 2014, the article reported.
 
Novo Nordisk filed for FDA approval of oral semaglutide, as well as for a new cardiovascular (CV) indication for a once-per-week injectable form of semaglutide, The American Journal of Managed Care reported. According to the article, if approved, oral semaglutide would be the first glucagon-like peptide-1 receptor agonist in a pill form. For oral semaglutide, Novo Nordisk submitted 2 new drug applications, one of which seeks approval to control blood glucose in type 2 diabetes and another indication to reduce major adverse CV events in adults with type 2 diabetes and established CV diseases, the article reported.
 



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$